A new type of bioreactor that can grow human veins in the lab has been developed by CSEM and ClexBio, a Nordics-based startup specialized in regenerative medicine.
CSEM has supported the Lausanne-based start-up Alithea Genomics in developing a technology capable of processing hundreds of ribonucleic acid (RNA) samples in a single tube, which translates to a significant reduction in reagents and manual effort in the overall workflow.
CSEM has supported Lausanne-based start-up Limula in its mission to make cell therapies more affordable, and to facilitate access to these personalized treatments.
A silent killer, liver cancer prompts race to improve organ replacements scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
Advanced bioreactors enable investigators to maintain viable tissue samples in closed systems under laboratory conditions. A multi-axis bioreactor has been designed for therapy testing to address the unmet need for the long-term culture of intervertebral discs under complex mechanical stimulation.